Globus Medical (GMED) Reaches $33.18 52-Week High; Healthcare Realty Trust (HR) Sentiment Is 1.36

June 19, 2017 - By marketbeat

The stock of Globus Medical Inc (NYSE:GMED) hit a new 52-week high and has $36.17 target or 9.00% above today’s $33.18 share price. The 8 months bullish chart indicates low risk for the $3.21B company. The 1-year high was reported on Jun, 19 by Barchart.com. If the $36.17 price target is reached, the company will be worth $288.90M more. About 21,075 shares traded. Globus Medical Inc (NYSE:GMED) has risen 30.88% since June 19, 2016 and is uptrending. It has outperformed by 14.18% the S&P500.

Healthcare Realty Trust Incorporated is a self-managed and self-administered real estate investment trust. The company has market cap of $4.14 billion. The Firm owns, leases, manages, acquires, finances, develops and redevelops real estate properties associated primarily with the delivery of outpatient healthcare services across the United States. It has a 37.32 P/E ratio. The Firm provided property management services for 146 healthcare-related properties across the nation, totaling approximately 10.3 million square feet, as of December 31, 2016.

About 85,052 shares traded. Healthcare Realty Trust Inc (HR) has risen 10.13% since June 19, 2016 and is uptrending. It has underperformed by 6.57% the S&P500.

Since January 1, 0001, it had 2 buys, and 4 sales for $468,877 activity.

Marble Harbor Investment Counsel Llc holds 2.64% of its portfolio in Healthcare Realty Trust Inc for 377,754 shares. American Assets Capital Advisers owns 120,000 shares or 2.39% of their US portfolio. Moreover, Channing Capital Management Llc has 1.61% invested in the company for 1.50 million shares. The Pennsylvania-based Cbre Clarion Securities Llc has invested 1.28% in the stock. Investment Counselors Of Maryland Llc, a Maryland-based fund reported 627,828 shares.

Analysts await Globus Medical Inc (NYSE:GMED) to report earnings on July, 25. They expect $0.31 EPS, up 6.90% or $0.02 from last year’s $0.29 per share. GMED’s profit will be $29.99 million for 26.76 P/E if the $0.31 EPS becomes a reality. After $0.32 actual EPS reported by Globus Medical Inc for the previous quarter, Wall Street now forecasts -3.13% negative EPS growth.

Among 11 analysts covering Globus Medical Inc (NYSE:GMED), 5 have Buy rating, 2 Sell and 4 Hold. Therefore 45% are positive. Globus Medical Inc has $40 highest and $21 lowest target. $31.17’s average target is -6.06% below currents $33.18 stock price. Globus Medical Inc had 22 analyst reports since August 3, 2015 according to SRatingsIntel. The stock of Globus Medical Inc (NYSE:GMED) has “Overweight” rating given on Monday, September 28 by Morgan Stanley. The firm has “Sell” rating given on Monday, May 16 by Goldman Sachs. The firm earned “Overweight” rating on Monday, September 14 by Morgan Stanley. The stock of Globus Medical Inc (NYSE:GMED) has “Buy” rating given on Wednesday, November 30 by Aegis Capital. Barclays Capital maintained the shares of GMED in report on Wednesday, July 27 with “Equalweight” rating. Leerink Swann upgraded the shares of GMED in report on Wednesday, April 12 to “Outperform” rating. Bank of America downgraded the shares of GMED in report on Friday, January 8 to “Underperform” rating. The stock of Globus Medical Inc (NYSE:GMED) has “Hold” rating given on Thursday, March 23 by Oppenheimer. Wells Fargo downgraded Globus Medical Inc (NYSE:GMED) on Wednesday, July 27 to “Market Perform” rating. UBS initiated the stock with “Buy” rating in Tuesday, September 22 report.

Globus Medical, Inc. is a medical device company. The company has market cap of $3.21 billion. The Firm is focused on developing products for patients with musculoskeletal disorders. It has a 30.41 P/E ratio. It is focused on products to treat patients with spine disorders.

Investors sentiment increased to 1.15 in 2016 Q4. Its up 0.27, from 0.88 in 2016Q3. It is positive, as 35 investors sold Globus Medical Inc shares while 57 reduced holdings. 48 funds opened positions while 58 raised stakes. 64.95 million shares or 1.58% more from 63.94 million shares in 2016Q3 were reported. Financial Bank Of Montreal Can holds 13,163 shares. Btim stated it has 0.21% in Globus Medical Inc (NYSE:GMED). Schwab Charles Investment holds 0.01% or 276,900 shares. 2.41 million were reported by Aberdeen Asset Management Public Ltd Co Uk. Moreover, Bancorporation Of America De has 0% invested in Globus Medical Inc (NYSE:GMED). Geneva Lc has invested 0.02% in Globus Medical Inc (NYSE:GMED). Finemark Retail Bank & reported 62 shares stake. Martingale Asset Mngmt Limited Partnership holds 0.01% of its portfolio in Globus Medical Inc (NYSE:GMED) for 36,906 shares. Voya Invest Mngmt Limited Liability has invested 0% in Globus Medical Inc (NYSE:GMED). Clinton Group owns 32,109 shares. Eagle Asset owns 138,554 shares for 0.02% of their portfolio. 118,841 are owned by Alliancebernstein Ltd Partnership. Raymond James And Assocs accumulated 0% or 55,622 shares. Gabelli Funds Limited Liability Company owns 230,500 shares. Wells Fargo & Mn has invested 0.01% in Globus Medical Inc (NYSE:GMED).

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: